Liposarcoma other imaging findings: Difference between revisions

	Liposarcoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Liposarcoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Liposarcoma other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Liposarcoma other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Liposarcoma other imaging findings
CDC on Liposarcoma other imaging findings
Liposarcoma other imaging findings in the news
Blogs on Liposarcoma other imaging findings
Directions to Hospitals Treating Liposarcoma
Risk calculators and risk factors for Liposarcoma other imaging findings

VisualWikitext

Latest revision as of 19:23, 29 May 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]; Alejandro Lemor, M.D. [3]Sabawoon Mirwais, M.B.B.S, M.D.[4]

Overview

Positron emission tomography (PET) scan is useful in cases where the liposarcoma is firm, deep, and has a size greater than 3 cm. PET scan may also help evaluate the grade and prognosis of the tumor, as well as its shrinkage following chemotherapy.

Other Imaging Findings

Positron emission tomography (PET)

Positron emission tomography (PET) is useful to evaluate cases of liposarcoma, especially when the tumor is firm, deep, and has a size greater than 3 cm.^[1]

PET scan is also useful to evaluate:

- Tumor grade
- Prognosis
- Tumor shrinkage following chemotherapy

Contrast-Enhanced Ultrasound (CEUS)

It can provide information by identifying different and specific enhancement patterns.^[2]

References

↑ "NCCN Guidelines for Patients - Soft Tissue Sarcoma".
↑ Aurash Naser-Tavakolian, Mittul Gulati, Vinay Duddalwar, Shefali Chopra, Manju Aron & Hooman Djaladat (2018). "Contrast-Enhanced Ultrasound of Spermatic Cord and Retroperitoneal Liposarcoma". Ultrasound quarterly. 34 (4): 292–296. doi:10.1097/RUQ.0000000000000372. PMID 30020269. Unknown parameter |month= ignored (help)

Template:WikiDoc Sources

[NCCN-1] "NCCN Guidelines for Patients - Soft Tissue Sarcoma".

[2] Aurash Naser-Tavakolian, Mittul Gulati, Vinay Duddalwar, Shefali Chopra, Manju Aron & Hooman Djaladat (2018). "Contrast-Enhanced Ultrasound of Spermatic Cord and Retroperitoneal Liposarcoma". Ultrasound quarterly. 34 (4): 292–296. doi:10.1097/RUQ.0000000000000372. PMID 30020269. Unknown parameter |month= ignored (help)

[1]

[2]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Liposarcoma}}
-{{CMG}}
+{{CMG}}; {{AE}} {{Ammu}}; {{AL}}{{Sab}}
 ==Overview==
-Other diagnostic imaging for liposarcoma include imaging of central nervous system and positron emission tomography (PET) scan.<ref name=NCCN>{{cite web | title = NCCN | url = http://www.nccn.org/professionals/physician_gls/f_guidelines.asp }}</ref>
+[[Positron emission tomography|Positron emission tomography (PET) scan]] is useful in cases where the liposarcoma is firm, deep, and has a size greater than 3 cm. [[Positron emission tomography|PET scan]] may also help evaluate the [[Grading (tumors)|grade]] and [[prognosis]] of the [[tumor]], as well as its shrinkage following [[chemotherapy]].
 ==Other Imaging Findings==
-===Imaging of central nervous system===
+===Positron emission tomography (PET)===
-Stage 4 liposarcoma can spread to brain and lungs. Imaging of central nervous system including brain and spinal cord helps to asses this metastasis
+* [[Positron emission tomography|Positron emission tomography (PET]]) is useful to evaluate cases of liposarcoma, especially when the [[tumor]] is firm, deep, and has a size greater than 3 cm.<ref name="NCCN">{{cite web | title = NCCN Guidelines for Patients - Soft Tissue Sarcoma | url =http://www.nccn.org/patients/guidelines/sarcoma/index.html#2 }}</ref>
+* [[Positron emission tomography|PET scan]] is also useful to evaluate:
+**[[Tumor]] [[Grading (tumors)|grade]]
+**[[Prognosis]]
+**[[Tumor]] shrinkage following [[chemotherapy]]
-===Positron emission tomography (PET)===
+=== Contrast-Enhanced Ultrasound (CEUS) ===
-Positron emission tomography (PET) is useful in assesing the tumor if the tumor size is greater than 3 cm, firm and is situated deep within the body.
+* It can provide information by identifying different and specific enhancement patterns.<ref>{{Cite journal
-It is useful for following purposes.
+ | author = [[Aurash Naser-Tavakolian]], [[Mittul Gulati]], [[Vinay Duddalwar]], [[Shefali Chopra]], [[Manju Aron]] & [[Hooman Djaladat]]
-*Assess grade of tumor
+ | title = Contrast-Enhanced Ultrasound of Spermatic Cord and Retroperitoneal Liposarcoma
-*Assess stage of tumor
+ | journal = [[Ultrasound quarterly]]
-*Prognosis
+ | volume = 34
-*Assess tumor shrinkage after chemotherapy.
+ | issue = 4
+ | pages = 292–296
+ | year = 2018
+ | month = December
+ | doi = 10.1097/RUQ.0000000000000372
+ | pmid = 30020269
+}}</ref>
 ==References==
@@ Line 23: / Line 35: @@
 [[Category:Disease]]
 [[Category:Types of cancer]]
-[[Category:Oncology]]
 [[Category:Surgery]]
 {{WikiDoc Help Menu}}
 {{WikiDoc Sources}}
+ [[Category:Up-To-Date]]
+[[Category:Oncology]]
+[[Category:Medicine]]